nodes	percent_of_prediction	percent_of_DWPC	metapath
Midazolam—CYP3A7—Simvastatin—atherosclerosis	0.0623	0.0877	CbGbCtD
Midazolam—CYP3A7-CYP3A51P—Simvastatin—atherosclerosis	0.0623	0.0877	CbGbCtD
Midazolam—CYP3A7—Lovastatin—atherosclerosis	0.061	0.0859	CbGbCtD
Midazolam—CYP3A7-CYP3A51P—Lovastatin—atherosclerosis	0.061	0.0859	CbGbCtD
Midazolam—CYP2B6—Simvastatin—atherosclerosis	0.0593	0.0835	CbGbCtD
Midazolam—CYP3A5—Rosuvastatin—atherosclerosis	0.0503	0.0708	CbGbCtD
Midazolam—CYP3A5—Simvastatin—atherosclerosis	0.0468	0.0658	CbGbCtD
Midazolam—CYP3A5—Pravastatin—atherosclerosis	0.0458	0.0644	CbGbCtD
Midazolam—CYP3A5—Lovastatin—atherosclerosis	0.0458	0.0644	CbGbCtD
Midazolam—ABCB1—Ezetimibe—atherosclerosis	0.0327	0.0461	CbGbCtD
Midazolam—ABCB1—Simvastatin—atherosclerosis	0.0304	0.0428	CbGbCtD
Midazolam—ABCB1—Pravastatin—atherosclerosis	0.0298	0.0419	CbGbCtD
Midazolam—ABCB1—Lovastatin—atherosclerosis	0.0298	0.0419	CbGbCtD
Midazolam—CYP3A4—Rosuvastatin—atherosclerosis	0.0196	0.0276	CbGbCtD
Midazolam—CYP3A4—Ezetimibe—atherosclerosis	0.0196	0.0276	CbGbCtD
Midazolam—CYP3A4—Simvastatin—atherosclerosis	0.0182	0.0257	CbGbCtD
Midazolam—CYP3A4—Pravastatin—atherosclerosis	0.0178	0.0251	CbGbCtD
Midazolam—CYP3A4—Lovastatin—atherosclerosis	0.0178	0.0251	CbGbCtD
Midazolam—Warmth—Niacin—atherosclerosis	0.00481	0.0324	CcSEcCtD
Midazolam—Sleep disturbance—Simvastatin—atherosclerosis	0.00297	0.02	CcSEcCtD
Midazolam—Sleep disturbance—Pravastatin—atherosclerosis	0.00269	0.0181	CcSEcCtD
Midazolam—Redness—Niacin—atherosclerosis	0.00227	0.0153	CcSEcCtD
Midazolam—Hyperventilation—Niacin—atherosclerosis	0.00222	0.015	CcSEcCtD
Midazolam—Laryngospasm—Niacin—atherosclerosis	0.00205	0.0138	CcSEcCtD
Midazolam—Tenderness—Lovastatin—atherosclerosis	0.00204	0.0138	CcSEcCtD
Midazolam—Nightmare—Rosuvastatin—atherosclerosis	0.00203	0.0137	CcSEcCtD
Midazolam—Feeling hot—Niacin—atherosclerosis	0.00195	0.0131	CcSEcCtD
Midazolam—Tenderness—Simvastatin—atherosclerosis	0.00191	0.0129	CcSEcCtD
Midazolam—Sleep disorder—Rosuvastatin—atherosclerosis	0.00176	0.0119	CcSEcCtD
Midazolam—Tenderness—Pravastatin—atherosclerosis	0.00173	0.0116	CcSEcCtD
Midazolam—Injury—Rosuvastatin—atherosclerosis	0.00166	0.0112	CcSEcCtD
Midazolam—Nightmare—Simvastatin—atherosclerosis	0.00161	0.0108	CcSEcCtD
Midazolam—Muscle twitching—Niacin—atherosclerosis	0.00156	0.0105	CcSEcCtD
Midazolam—Skin exfoliation—Niacin—atherosclerosis	0.00146	0.00984	CcSEcCtD
Midazolam—Nightmare—Pravastatin—atherosclerosis	0.00146	0.0098	CcSEcCtD
Midazolam—Injury—Lovastatin—atherosclerosis	0.00141	0.00948	CcSEcCtD
Midazolam—Sleep disorder—Simvastatin—atherosclerosis	0.0014	0.00941	CcSEcCtD
Midazolam—Swelling—Simvastatin—atherosclerosis	0.00137	0.00924	CcSEcCtD
Midazolam—Muscular weakness—Rosuvastatin—atherosclerosis	0.00135	0.00907	CcSEcCtD
Midazolam—Sleep disorder—Pravastatin—atherosclerosis	0.00126	0.00851	CcSEcCtD
Midazolam—Injury—Pravastatin—atherosclerosis	0.00119	0.00802	CcSEcCtD
Midazolam—Depression—Rosuvastatin—atherosclerosis	0.00117	0.0079	CcSEcCtD
Midazolam—Neuropathy peripheral—Rosuvastatin—atherosclerosis	0.00115	0.00777	CcSEcCtD
Midazolam—Nasopharyngitis—Ezetimibe—atherosclerosis	0.00113	0.00764	CcSEcCtD
Midazolam—Muscular weakness—Ezetimibe—atherosclerosis	0.00112	0.00754	CcSEcCtD
Midazolam—Diplopia—Pravastatin—atherosclerosis	0.00109	0.00737	CcSEcCtD
Midazolam—Affect lability—Pravastatin—atherosclerosis	0.00108	0.00725	CcSEcCtD
Midazolam—Muscular weakness—Simvastatin—atherosclerosis	0.00107	0.00719	CcSEcCtD
Midazolam—Mood swings—Pravastatin—atherosclerosis	0.00104	0.00698	CcSEcCtD
Midazolam—Muscular weakness—Niacin—atherosclerosis	0.00098	0.0066	CcSEcCtD
Midazolam—Nasopharyngitis—Pravastatin—atherosclerosis	0.000979	0.00659	CcSEcCtD
Midazolam—Neuropathy peripheral—Lovastatin—atherosclerosis	0.000977	0.00658	CcSEcCtD
Midazolam—Muscular weakness—Pravastatin—atherosclerosis	0.000965	0.0065	CcSEcCtD
Midazolam—Neuropathy peripheral—Ezetimibe—atherosclerosis	0.000959	0.00646	CcSEcCtD
Midazolam—Depression—Simvastatin—atherosclerosis	0.00093	0.00626	CcSEcCtD
Midazolam—Mental disorder—Rosuvastatin—atherosclerosis	0.000925	0.00623	CcSEcCtD
Midazolam—Neuropathy peripheral—Simvastatin—atherosclerosis	0.000914	0.00616	CcSEcCtD
Midazolam—Connective tissue disorder—Ezetimibe—atherosclerosis	0.000863	0.00581	CcSEcCtD
Midazolam—Depression—Pravastatin—atherosclerosis	0.000841	0.00566	CcSEcCtD
Midazolam—Neuropathy peripheral—Pravastatin—atherosclerosis	0.000827	0.00557	CcSEcCtD
Midazolam—Chills—Lovastatin—atherosclerosis	0.000803	0.00541	CcSEcCtD
Midazolam—Cough—Rosuvastatin—atherosclerosis	0.000802	0.0054	CcSEcCtD
Midazolam—Immune system disorder—Ezetimibe—atherosclerosis	0.000793	0.00534	CcSEcCtD
Midazolam—Mediastinal disorder—Ezetimibe—atherosclerosis	0.000791	0.00533	CcSEcCtD
Midazolam—Mental disorder—Ezetimibe—atherosclerosis	0.000769	0.00518	CcSEcCtD
Midazolam—Erythema—Ezetimibe—atherosclerosis	0.000764	0.00515	CcSEcCtD
Midazolam—Confusional state—Rosuvastatin—atherosclerosis	0.000757	0.0051	CcSEcCtD
Midazolam—Chills—Simvastatin—atherosclerosis	0.000751	0.00506	CcSEcCtD
Midazolam—Visual impairment—Niacin—atherosclerosis	0.000741	0.00499	CcSEcCtD
Midazolam—Nervous system disorder—Rosuvastatin—atherosclerosis	0.000736	0.00496	CcSEcCtD
Midazolam—Vision blurred—Lovastatin—atherosclerosis	0.000734	0.00495	CcSEcCtD
Midazolam—Mental disorder—Simvastatin—atherosclerosis	0.000734	0.00494	CcSEcCtD
Midazolam—Tremor—Lovastatin—atherosclerosis	0.00073	0.00492	CcSEcCtD
Midazolam—Visual impairment—Pravastatin—atherosclerosis	0.00073	0.00491	CcSEcCtD
Midazolam—Erythema—Simvastatin—atherosclerosis	0.000729	0.00491	CcSEcCtD
Midazolam—Eye disorder—Niacin—atherosclerosis	0.000719	0.00484	CcSEcCtD
Midazolam—Cardiac disorder—Pravastatin—atherosclerosis	0.000703	0.00473	CcSEcCtD
Midazolam—Vertigo—Lovastatin—atherosclerosis	0.0007	0.00471	CcSEcCtD
Midazolam—Chills—Niacin—atherosclerosis	0.00069	0.00465	CcSEcCtD
Midazolam—Vision blurred—Simvastatin—atherosclerosis	0.000687	0.00463	CcSEcCtD
Midazolam—Tremor—Simvastatin—atherosclerosis	0.000683	0.0046	CcSEcCtD
Midazolam—Chills—Pravastatin—atherosclerosis	0.000679	0.00457	CcSEcCtD
Midazolam—Paraesthesia—Rosuvastatin—atherosclerosis	0.000674	0.00454	CcSEcCtD
Midazolam—Erythema—Niacin—atherosclerosis	0.000669	0.00451	CcSEcCtD
Midazolam—Cough—Ezetimibe—atherosclerosis	0.000667	0.00449	CcSEcCtD
Midazolam—Anxiety—Lovastatin—atherosclerosis	0.000661	0.00445	CcSEcCtD
Midazolam—Dyspepsia—Rosuvastatin—atherosclerosis	0.000661	0.00445	CcSEcCtD
Midazolam—Tension—Niacin—atherosclerosis	0.000657	0.00442	CcSEcCtD
Midazolam—Vertigo—Simvastatin—atherosclerosis	0.000655	0.00441	CcSEcCtD
Midazolam—Nervousness—Niacin—atherosclerosis	0.00065	0.00438	CcSEcCtD
Midazolam—Dry mouth—Lovastatin—atherosclerosis	0.000649	0.00437	CcSEcCtD
Midazolam—Tension—Pravastatin—atherosclerosis	0.000647	0.00435	CcSEcCtD
Midazolam—Unspecified disorder of skin and subcutaneous tissue—Ezetimibe—atherosclerosis	0.000646	0.00435	CcSEcCtD
Midazolam—Constipation—Rosuvastatin—atherosclerosis	0.000642	0.00432	CcSEcCtD
Midazolam—Pain—Rosuvastatin—atherosclerosis	0.000642	0.00432	CcSEcCtD
Midazolam—Confusional state—Lovastatin—atherosclerosis	0.000641	0.00432	CcSEcCtD
Midazolam—Nervousness—Pravastatin—atherosclerosis	0.00064	0.00431	CcSEcCtD
Midazolam—Dry mouth—Ezetimibe—atherosclerosis	0.000636	0.00429	CcSEcCtD
Midazolam—Anaphylactic shock—Lovastatin—atherosclerosis	0.000636	0.00428	CcSEcCtD
Midazolam—Vision blurred—Niacin—atherosclerosis	0.000631	0.00425	CcSEcCtD
Midazolam—Confusional state—Ezetimibe—atherosclerosis	0.000629	0.00424	CcSEcCtD
Midazolam—Anaphylactic shock—Ezetimibe—atherosclerosis	0.000624	0.0042	CcSEcCtD
Midazolam—Vision blurred—Pravastatin—atherosclerosis	0.000621	0.00418	CcSEcCtD
Midazolam—Feeling abnormal—Rosuvastatin—atherosclerosis	0.000618	0.00416	CcSEcCtD
Midazolam—Anxiety—Simvastatin—atherosclerosis	0.000618	0.00416	CcSEcCtD
Midazolam—Tremor—Pravastatin—atherosclerosis	0.000617	0.00416	CcSEcCtD
Midazolam—Nervous system disorder—Ezetimibe—atherosclerosis	0.000612	0.00412	CcSEcCtD
Midazolam—Skin disorder—Ezetimibe—atherosclerosis	0.000606	0.00408	CcSEcCtD
Midazolam—Vertigo—Niacin—atherosclerosis	0.000601	0.00405	CcSEcCtD
Midazolam—Syncope—Niacin—atherosclerosis	0.0006	0.00404	CcSEcCtD
Midazolam—Confusional state—Simvastatin—atherosclerosis	0.0006	0.00404	CcSEcCtD
Midazolam—Urticaria—Rosuvastatin—atherosclerosis	0.000596	0.00401	CcSEcCtD
Midazolam—Anaphylactic shock—Simvastatin—atherosclerosis	0.000595	0.00401	CcSEcCtD
Midazolam—Vertigo—Pravastatin—atherosclerosis	0.000592	0.00399	CcSEcCtD
Midazolam—Cough—Niacin—atherosclerosis	0.000584	0.00393	CcSEcCtD
Midazolam—Cough—Pravastatin—atherosclerosis	0.000575	0.00387	CcSEcCtD
Midazolam—Paraesthesia—Lovastatin—atherosclerosis	0.000571	0.00385	CcSEcCtD
Midazolam—Dyspnoea—Lovastatin—atherosclerosis	0.000567	0.00382	CcSEcCtD
Midazolam—Unspecified disorder of skin and subcutaneous tissue—Niacin—atherosclerosis	0.000566	0.00381	CcSEcCtD
Midazolam—Paraesthesia—Ezetimibe—atherosclerosis	0.00056	0.00377	CcSEcCtD
Midazolam—Dyspepsia—Lovastatin—atherosclerosis	0.00056	0.00377	CcSEcCtD
Midazolam—Anxiety—Pravastatin—atherosclerosis	0.000559	0.00376	CcSEcCtD
Midazolam—Dry mouth—Niacin—atherosclerosis	0.000557	0.00375	CcSEcCtD
Midazolam—Dyspnoea—Ezetimibe—atherosclerosis	0.000556	0.00374	CcSEcCtD
Midazolam—Hypersensitivity—Rosuvastatin—atherosclerosis	0.000553	0.00372	CcSEcCtD
Midazolam—Dyspepsia—Ezetimibe—atherosclerosis	0.000549	0.0037	CcSEcCtD
Midazolam—Fatigue—Lovastatin—atherosclerosis	0.000548	0.00369	CcSEcCtD
Midazolam—Anaphylactic shock—Niacin—atherosclerosis	0.000546	0.00368	CcSEcCtD
Midazolam—Pain—Lovastatin—atherosclerosis	0.000544	0.00366	CcSEcCtD
Midazolam—Constipation—Lovastatin—atherosclerosis	0.000544	0.00366	CcSEcCtD
Midazolam—Confusional state—Pravastatin—atherosclerosis	0.000542	0.00365	CcSEcCtD
Midazolam—Gastrointestinal disorder—Ezetimibe—atherosclerosis	0.000539	0.00363	CcSEcCtD
Midazolam—Asthenia—Rosuvastatin—atherosclerosis	0.000538	0.00363	CcSEcCtD
Midazolam—Anaphylactic shock—Pravastatin—atherosclerosis	0.000538	0.00362	CcSEcCtD
Midazolam—Fatigue—Ezetimibe—atherosclerosis	0.000538	0.00362	CcSEcCtD
Midazolam—Shock—Niacin—atherosclerosis	0.000537	0.00362	CcSEcCtD
Midazolam—Paraesthesia—Simvastatin—atherosclerosis	0.000534	0.0036	CcSEcCtD
Midazolam—Pain—Ezetimibe—atherosclerosis	0.000533	0.00359	CcSEcCtD
Midazolam—Constipation—Ezetimibe—atherosclerosis	0.000533	0.00359	CcSEcCtD
Midazolam—Tachycardia—Niacin—atherosclerosis	0.000533	0.00359	CcSEcCtD
Midazolam—Pruritus—Rosuvastatin—atherosclerosis	0.000531	0.00358	CcSEcCtD
Midazolam—Skin disorder—Niacin—atherosclerosis	0.000531	0.00357	CcSEcCtD
Midazolam—Dyspnoea—Simvastatin—atherosclerosis	0.00053	0.00357	CcSEcCtD
Midazolam—Feeling abnormal—Lovastatin—atherosclerosis	0.000524	0.00353	CcSEcCtD
Midazolam—Dyspepsia—Simvastatin—atherosclerosis	0.000524	0.00353	CcSEcCtD
Midazolam—Feeling abnormal—Ezetimibe—atherosclerosis	0.000514	0.00346	CcSEcCtD
Midazolam—Gastrointestinal disorder—Simvastatin—atherosclerosis	0.000514	0.00346	CcSEcCtD
Midazolam—Fatigue—Simvastatin—atherosclerosis	0.000513	0.00345	CcSEcCtD
Midazolam—Hypotension—Niacin—atherosclerosis	0.00051	0.00344	CcSEcCtD
Midazolam—Constipation—Simvastatin—atherosclerosis	0.000509	0.00343	CcSEcCtD
Midazolam—Pain—Simvastatin—atherosclerosis	0.000509	0.00343	CcSEcCtD
Midazolam—Urticaria—Lovastatin—atherosclerosis	0.000505	0.0034	CcSEcCtD
Midazolam—Dizziness—Rosuvastatin—atherosclerosis	0.000496	0.00334	CcSEcCtD
Midazolam—Urticaria—Ezetimibe—atherosclerosis	0.000496	0.00334	CcSEcCtD
Midazolam—Paraesthesia—Niacin—atherosclerosis	0.00049	0.0033	CcSEcCtD
Midazolam—Feeling abnormal—Simvastatin—atherosclerosis	0.00049	0.0033	CcSEcCtD
Midazolam—Dyspnoea—Niacin—atherosclerosis	0.000487	0.00328	CcSEcCtD
Midazolam—Somnolence—Niacin—atherosclerosis	0.000486	0.00327	CcSEcCtD
Midazolam—Paraesthesia—Pravastatin—atherosclerosis	0.000483	0.00325	CcSEcCtD
Midazolam—Dyspepsia—Niacin—atherosclerosis	0.000481	0.00324	CcSEcCtD
Midazolam—Dyspnoea—Pravastatin—atherosclerosis	0.000479	0.00323	CcSEcCtD
Midazolam—Dyspepsia—Pravastatin—atherosclerosis	0.000473	0.00319	CcSEcCtD
Midazolam—Rash—Rosuvastatin—atherosclerosis	0.000473	0.00319	CcSEcCtD
Midazolam—Dermatitis—Rosuvastatin—atherosclerosis	0.000473	0.00318	CcSEcCtD
Midazolam—Urticaria—Simvastatin—atherosclerosis	0.000473	0.00318	CcSEcCtD
Midazolam—Gastrointestinal disorder—Niacin—atherosclerosis	0.000472	0.00318	CcSEcCtD
Midazolam—Headache—Rosuvastatin—atherosclerosis	0.00047	0.00317	CcSEcCtD
Midazolam—Hypersensitivity—Lovastatin—atherosclerosis	0.000469	0.00316	CcSEcCtD
Midazolam—Pain—Niacin—atherosclerosis	0.000467	0.00315	CcSEcCtD
Midazolam—Fatigue—Pravastatin—atherosclerosis	0.000464	0.00312	CcSEcCtD
Midazolam—Constipation—Pravastatin—atherosclerosis	0.00046	0.0031	CcSEcCtD
Midazolam—Pain—Pravastatin—atherosclerosis	0.00046	0.0031	CcSEcCtD
Midazolam—Hypersensitivity—Ezetimibe—atherosclerosis	0.00046	0.00309	CcSEcCtD
Midazolam—Asthenia—Lovastatin—atherosclerosis	0.000456	0.00307	CcSEcCtD
Midazolam—Pruritus—Lovastatin—atherosclerosis	0.00045	0.00303	CcSEcCtD
Midazolam—Asthenia—Ezetimibe—atherosclerosis	0.000448	0.00301	CcSEcCtD
Midazolam—Nausea—Rosuvastatin—atherosclerosis	0.000446	0.003	CcSEcCtD
Midazolam—Feeling abnormal—Pravastatin—atherosclerosis	0.000443	0.00298	CcSEcCtD
Midazolam—Pruritus—Ezetimibe—atherosclerosis	0.000441	0.00297	CcSEcCtD
Midazolam—Hypersensitivity—Simvastatin—atherosclerosis	0.000438	0.00295	CcSEcCtD
Midazolam—Urticaria—Niacin—atherosclerosis	0.000434	0.00292	CcSEcCtD
Midazolam—Urticaria—Pravastatin—atherosclerosis	0.000427	0.00288	CcSEcCtD
Midazolam—Asthenia—Simvastatin—atherosclerosis	0.000427	0.00287	CcSEcCtD
Midazolam—Pruritus—Simvastatin—atherosclerosis	0.000421	0.00283	CcSEcCtD
Midazolam—Dizziness—Lovastatin—atherosclerosis	0.000421	0.00283	CcSEcCtD
Midazolam—Dizziness—Ezetimibe—atherosclerosis	0.000413	0.00278	CcSEcCtD
Midazolam—Vomiting—Lovastatin—atherosclerosis	0.000404	0.00272	CcSEcCtD
Midazolam—Hypersensitivity—Niacin—atherosclerosis	0.000402	0.00271	CcSEcCtD
Midazolam—Rash—Lovastatin—atherosclerosis	0.000401	0.0027	CcSEcCtD
Midazolam—Dermatitis—Lovastatin—atherosclerosis	0.000401	0.0027	CcSEcCtD
Midazolam—Headache—Lovastatin—atherosclerosis	0.000398	0.00268	CcSEcCtD
Midazolam—Vomiting—Ezetimibe—atherosclerosis	0.000397	0.00267	CcSEcCtD
Midazolam—Hypersensitivity—Pravastatin—atherosclerosis	0.000396	0.00267	CcSEcCtD
Midazolam—Dizziness—Simvastatin—atherosclerosis	0.000393	0.00265	CcSEcCtD
Midazolam—Rash—Ezetimibe—atherosclerosis	0.000393	0.00265	CcSEcCtD
Midazolam—Dermatitis—Ezetimibe—atherosclerosis	0.000393	0.00265	CcSEcCtD
Midazolam—Asthenia—Niacin—atherosclerosis	0.000392	0.00264	CcSEcCtD
Midazolam—Headache—Ezetimibe—atherosclerosis	0.000391	0.00263	CcSEcCtD
Midazolam—Pruritus—Niacin—atherosclerosis	0.000386	0.0026	CcSEcCtD
Midazolam—Asthenia—Pravastatin—atherosclerosis	0.000386	0.0026	CcSEcCtD
Midazolam—Pruritus—Pravastatin—atherosclerosis	0.000381	0.00256	CcSEcCtD
Midazolam—Vomiting—Simvastatin—atherosclerosis	0.000378	0.00255	CcSEcCtD
Midazolam—Nausea—Lovastatin—atherosclerosis	0.000378	0.00254	CcSEcCtD
Midazolam—Rash—Simvastatin—atherosclerosis	0.000375	0.00253	CcSEcCtD
Midazolam—Dermatitis—Simvastatin—atherosclerosis	0.000375	0.00252	CcSEcCtD
Midazolam—Headache—Simvastatin—atherosclerosis	0.000373	0.00251	CcSEcCtD
Midazolam—Nausea—Ezetimibe—atherosclerosis	0.000371	0.00249	CcSEcCtD
Midazolam—Dizziness—Niacin—atherosclerosis	0.000361	0.00243	CcSEcCtD
Midazolam—Dizziness—Pravastatin—atherosclerosis	0.000356	0.00239	CcSEcCtD
Midazolam—Nausea—Simvastatin—atherosclerosis	0.000353	0.00238	CcSEcCtD
Midazolam—Vomiting—Niacin—atherosclerosis	0.000347	0.00234	CcSEcCtD
Midazolam—Rash—Niacin—atherosclerosis	0.000344	0.00232	CcSEcCtD
Midazolam—Dermatitis—Niacin—atherosclerosis	0.000344	0.00232	CcSEcCtD
Midazolam—Headache—Niacin—atherosclerosis	0.000342	0.0023	CcSEcCtD
Midazolam—Vomiting—Pravastatin—atherosclerosis	0.000342	0.0023	CcSEcCtD
Midazolam—Rash—Pravastatin—atherosclerosis	0.000339	0.00228	CcSEcCtD
Midazolam—Dermatitis—Pravastatin—atherosclerosis	0.000339	0.00228	CcSEcCtD
Midazolam—Headache—Pravastatin—atherosclerosis	0.000337	0.00227	CcSEcCtD
Midazolam—Nausea—Niacin—atherosclerosis	0.000324	0.00218	CcSEcCtD
Midazolam—Nausea—Pravastatin—atherosclerosis	0.000319	0.00215	CcSEcCtD
Midazolam—Chlorprothixene—HRH1—atherosclerosis	0.000112	0.521	CrCbGaD
Midazolam—Ketazolam—ALB—atherosclerosis	4.65e-05	0.216	CrCbGaD
Midazolam—Clonazepam—ALB—atherosclerosis	3.75e-05	0.174	CrCbGaD
Midazolam—Diazepam—ALB—atherosclerosis	1.92e-05	0.0892	CrCbGaD
Midazolam—SLC22A1—Metabolism—LDLR—atherosclerosis	1.92e-05	0.000136	CbGpPWpGaD
Midazolam—CYP2E1—Metabolism—LPA—atherosclerosis	1.9e-05	0.000135	CbGpPWpGaD
Midazolam—CYP3A5—Metabolism—LPA—atherosclerosis	1.9e-05	0.000135	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—ABCG1—atherosclerosis	1.89e-05	0.000134	CbGpPWpGaD
Midazolam—UGT1A4—Metabolism—INS—atherosclerosis	1.89e-05	0.000134	CbGpPWpGaD
Midazolam—CYP2B6—Metabolism—BGN—atherosclerosis	1.88e-05	0.000134	CbGpPWpGaD
Midazolam—SLC22A1—Metabolism—CETP—atherosclerosis	1.87e-05	0.000133	CbGpPWpGaD
Midazolam—CYP2B6—Metabolism—APOA5—atherosclerosis	1.86e-05	0.000132	CbGpPWpGaD
Midazolam—ABCB1—Integrated Pancreatic Cancer Pathway—NFKB1—atherosclerosis	1.86e-05	0.000132	CbGpPWpGaD
Midazolam—CYP2E1—Metabolism—BGN—atherosclerosis	1.84e-05	0.000131	CbGpPWpGaD
Midazolam—CYP3A5—Metabolism—BGN—atherosclerosis	1.84e-05	0.000131	CbGpPWpGaD
Midazolam—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK8—atherosclerosis	1.83e-05	0.00013	CbGpPWpGaD
Midazolam—CYP2E1—Metabolism—APOA5—atherosclerosis	1.82e-05	0.000129	CbGpPWpGaD
Midazolam—CYP3A7—Metabolism—HMGCR—atherosclerosis	1.82e-05	0.000129	CbGpPWpGaD
Midazolam—CYP3A5—Metabolism—APOA5—atherosclerosis	1.82e-05	0.000129	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—LDLRAP1—atherosclerosis	1.81e-05	0.000128	CbGpPWpGaD
Midazolam—SLC22A1—Metabolism—SCARB1—atherosclerosis	1.79e-05	0.000127	CbGpPWpGaD
Midazolam—CYP2B6—Metabolism—PLA2G1B—atherosclerosis	1.79e-05	0.000127	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—FABP4—atherosclerosis	1.78e-05	0.000126	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—LCAT—atherosclerosis	1.78e-05	0.000126	CbGpPWpGaD
Midazolam—ABCB1—Transmembrane transport of small molecules—PLG—atherosclerosis	1.76e-05	0.000125	CbGpPWpGaD
Midazolam—CYP2E1—Metabolism—PLA2G1B—atherosclerosis	1.76e-05	0.000125	CbGpPWpGaD
Midazolam—CYP3A5—Metabolism—PLA2G1B—atherosclerosis	1.75e-05	0.000124	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—APOA4—atherosclerosis	1.75e-05	0.000124	CbGpPWpGaD
Midazolam—CYP2B6—Metabolism—ALOX5—atherosclerosis	1.73e-05	0.000123	CbGpPWpGaD
Midazolam—UGT1A4—Metabolism—ALB—atherosclerosis	1.73e-05	0.000123	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—CYP7A1—atherosclerosis	1.71e-05	0.000122	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—PLTP—atherosclerosis	1.7e-05	0.000121	CbGpPWpGaD
Midazolam—CYP2E1—Metabolism—ALOX5—atherosclerosis	1.7e-05	0.00012	CbGpPWpGaD
Midazolam—SLC22A1—Metabolism—HMGCR—atherosclerosis	1.69e-05	0.00012	CbGpPWpGaD
Midazolam—CYP3A5—Metabolism—ALOX5—atherosclerosis	1.69e-05	0.00012	CbGpPWpGaD
Midazolam—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—atherosclerosis	1.69e-05	0.00012	CbGpPWpGaD
Midazolam—SLC22A1—Transmembrane transport of small molecules—ALB—atherosclerosis	1.66e-05	0.000118	CbGpPWpGaD
Midazolam—UGT1A4—Metabolism—NOS3—atherosclerosis	1.66e-05	0.000118	CbGpPWpGaD
Midazolam—CYP3A7—Metabolism—ABCA1—atherosclerosis	1.62e-05	0.000115	CbGpPWpGaD
Midazolam—ABCB1—Transmembrane transport of small molecules—HMOX1—atherosclerosis	1.62e-05	0.000115	CbGpPWpGaD
Midazolam—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK3—atherosclerosis	1.6e-05	0.000113	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—CYP27A1—atherosclerosis	1.58e-05	0.000112	CbGpPWpGaD
Midazolam—ABCB1—Transmembrane transport of small molecules—APOB—atherosclerosis	1.55e-05	0.00011	CbGpPWpGaD
Midazolam—CYP2B6—Metabolism—NAMPT—atherosclerosis	1.55e-05	0.00011	CbGpPWpGaD
Midazolam—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—atherosclerosis	1.55e-05	0.00011	CbGpPWpGaD
Midazolam—CYP2B6—Metabolism—LIPC—atherosclerosis	1.54e-05	0.00011	CbGpPWpGaD
Midazolam—CYP2B6—Metabolism—APOC3—atherosclerosis	1.53e-05	0.000109	CbGpPWpGaD
Midazolam—CYP2B6—Metabolism—LDLR—atherosclerosis	1.52e-05	0.000108	CbGpPWpGaD
Midazolam—CYP2E1—Metabolism—NAMPT—atherosclerosis	1.52e-05	0.000108	CbGpPWpGaD
Midazolam—CYP3A5—Metabolism—NAMPT—atherosclerosis	1.52e-05	0.000108	CbGpPWpGaD
Midazolam—UGT1A4—Metabolism—PTGS2—atherosclerosis	1.51e-05	0.000107	CbGpPWpGaD
Midazolam—CYP2E1—Metabolism—LIPC—atherosclerosis	1.51e-05	0.000107	CbGpPWpGaD
Midazolam—SLC22A1—Metabolism—ABCA1—atherosclerosis	1.51e-05	0.000107	CbGpPWpGaD
Midazolam—CYP3A5—Metabolism—LIPC—atherosclerosis	1.51e-05	0.000107	CbGpPWpGaD
Midazolam—CYP2E1—Metabolism—APOC3—atherosclerosis	1.5e-05	0.000107	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—ALOX15—atherosclerosis	1.5e-05	0.000107	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—APOA2—atherosclerosis	1.5e-05	0.000107	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—ALOX5AP—atherosclerosis	1.5e-05	0.000107	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—PLA2G2A—atherosclerosis	1.5e-05	0.000107	CbGpPWpGaD
Midazolam—CYP3A5—Metabolism—APOC3—atherosclerosis	1.5e-05	0.000106	CbGpPWpGaD
Midazolam—CYP2E1—Metabolism—LDLR—atherosclerosis	1.49e-05	0.000106	CbGpPWpGaD
Midazolam—CYP3A5—Metabolism—LDLR—atherosclerosis	1.49e-05	0.000106	CbGpPWpGaD
Midazolam—CYP2B6—Metabolism—CETP—atherosclerosis	1.49e-05	0.000106	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—ABCG5—atherosclerosis	1.48e-05	0.000105	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—LTA4H—atherosclerosis	1.47e-05	0.000105	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—ABCG8—atherosclerosis	1.47e-05	0.000105	CbGpPWpGaD
Midazolam—CYP2E1—Metabolism—CETP—atherosclerosis	1.46e-05	0.000104	CbGpPWpGaD
Midazolam—CYP3A5—Metabolism—CETP—atherosclerosis	1.46e-05	0.000103	CbGpPWpGaD
Midazolam—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—atherosclerosis	1.45e-05	0.000103	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—LPA—atherosclerosis	1.43e-05	0.000102	CbGpPWpGaD
Midazolam—CYP2B6—Metabolism—SCARB1—atherosclerosis	1.43e-05	0.000101	CbGpPWpGaD
Midazolam—CYP2E1—Metabolism—SCARB1—atherosclerosis	1.4e-05	9.91e-05	CbGpPWpGaD
Midazolam—CYP3A5—Metabolism—SCARB1—atherosclerosis	1.39e-05	9.89e-05	CbGpPWpGaD
Midazolam—CYP3A7—Metabolism—HMOX1—atherosclerosis	1.39e-05	9.88e-05	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—BGN—atherosclerosis	1.39e-05	9.85e-05	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—APOA5—atherosclerosis	1.37e-05	9.75e-05	CbGpPWpGaD
Midazolam—CYP2B6—Metabolism—HMGCR—atherosclerosis	1.35e-05	9.56e-05	CbGpPWpGaD
Midazolam—CYP3A7—Metabolism—APOB—atherosclerosis	1.33e-05	9.47e-05	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—PLA2G1B—atherosclerosis	1.32e-05	9.39e-05	CbGpPWpGaD
Midazolam—CYP2E1—Metabolism—HMGCR—atherosclerosis	1.32e-05	9.36e-05	CbGpPWpGaD
Midazolam—CYP3A5—Metabolism—HMGCR—atherosclerosis	1.32e-05	9.34e-05	CbGpPWpGaD
Midazolam—ABCB1—Transmembrane transport of small molecules—PPARA—atherosclerosis	1.31e-05	9.3e-05	CbGpPWpGaD
Midazolam—CYP3A7—Metabolism—GSTM1—atherosclerosis	1.3e-05	9.21e-05	CbGpPWpGaD
Midazolam—SLC22A1—Metabolism—HMOX1—atherosclerosis	1.3e-05	9.2e-05	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—ALOX5—atherosclerosis	1.28e-05	9.07e-05	CbGpPWpGaD
Midazolam—CYP3A7—Metabolism—LPL—atherosclerosis	1.27e-05	9.04e-05	CbGpPWpGaD
Midazolam—CYP3A7—Metabolism—GPX1—atherosclerosis	1.24e-05	8.82e-05	CbGpPWpGaD
Midazolam—SLC22A1—Metabolism—APOB—atherosclerosis	1.24e-05	8.81e-05	CbGpPWpGaD
Midazolam—ABCB1—Transmembrane transport of small molecules—APOA1—atherosclerosis	1.23e-05	8.72e-05	CbGpPWpGaD
Midazolam—CYP4B1—Metabolism—AKT1—atherosclerosis	1.22e-05	8.64e-05	CbGpPWpGaD
Midazolam—CYP3A7—Metabolism—CD36—atherosclerosis	1.21e-05	8.59e-05	CbGpPWpGaD
Midazolam—SLC22A1—Metabolism—GSTM1—atherosclerosis	1.21e-05	8.57e-05	CbGpPWpGaD
Midazolam—CYP2B6—Metabolism—ABCA1—atherosclerosis	1.2e-05	8.52e-05	CbGpPWpGaD
Midazolam—SLC22A1—Metabolism—LPL—atherosclerosis	1.19e-05	8.41e-05	CbGpPWpGaD
Midazolam—CYP2E1—Metabolism—ABCA1—atherosclerosis	1.18e-05	8.34e-05	CbGpPWpGaD
Midazolam—CYP3A5—Metabolism—ABCA1—atherosclerosis	1.17e-05	8.33e-05	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—ABCG1—atherosclerosis	1.17e-05	8.27e-05	CbGpPWpGaD
Midazolam—SLC22A1—Metabolism—GPX1—atherosclerosis	1.16e-05	8.21e-05	CbGpPWpGaD
Midazolam—CYP3A7—Metabolism—MTHFR—atherosclerosis	1.15e-05	8.14e-05	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—NAMPT—atherosclerosis	1.15e-05	8.13e-05	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—LIPC—atherosclerosis	1.14e-05	8.08e-05	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—APOC3—atherosclerosis	1.13e-05	8.03e-05	CbGpPWpGaD
Midazolam—SLC22A1—Metabolism—CD36—atherosclerosis	1.13e-05	7.99e-05	CbGpPWpGaD
Midazolam—CYP3A7—Metabolism—PPARA—atherosclerosis	1.13e-05	7.99e-05	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—LDLR—atherosclerosis	1.12e-05	7.98e-05	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—CETP—atherosclerosis	1.1e-05	7.8e-05	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—FABP4—atherosclerosis	1.1e-05	7.77e-05	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—LCAT—atherosclerosis	1.1e-05	7.77e-05	CbGpPWpGaD
Midazolam—CYP3A7—Metabolism—AGT—atherosclerosis	1.09e-05	7.73e-05	CbGpPWpGaD
Midazolam—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—atherosclerosis	1.08e-05	7.65e-05	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—APOA4—atherosclerosis	1.08e-05	7.63e-05	CbGpPWpGaD
Midazolam—CYP3A7—Metabolism—APOE—atherosclerosis	1.07e-05	7.58e-05	CbGpPWpGaD
Midazolam—SLC22A1—Metabolism—MTHFR—atherosclerosis	1.07e-05	7.57e-05	CbGpPWpGaD
Midazolam—CYP3A7—Metabolism—CAV1—atherosclerosis	1.06e-05	7.51e-05	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—CYP7A1—atherosclerosis	1.06e-05	7.5e-05	CbGpPWpGaD
Midazolam—CYP3A7—Metabolism—APOA1—atherosclerosis	1.06e-05	7.49e-05	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—SCARB1—atherosclerosis	1.05e-05	7.47e-05	CbGpPWpGaD
Midazolam—SLC22A1—Metabolism—PPARA—atherosclerosis	1.05e-05	7.43e-05	CbGpPWpGaD
Midazolam—CYP2B6—Metabolism—HMOX1—atherosclerosis	1.03e-05	7.31e-05	CbGpPWpGaD
Midazolam—SLC22A1—Metabolism—AGT—atherosclerosis	1.01e-05	7.2e-05	CbGpPWpGaD
Midazolam—CYP2E1—Metabolism—HMOX1—atherosclerosis	1.01e-05	7.16e-05	CbGpPWpGaD
Midazolam—CYP3A5—Metabolism—HMOX1—atherosclerosis	1.01e-05	7.14e-05	CbGpPWpGaD
Midazolam—SLC22A1—Metabolism—APOE—atherosclerosis	9.94e-06	7.05e-05	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—HMGCR—atherosclerosis	9.93e-06	7.05e-05	CbGpPWpGaD
Midazolam—CYP2B6—Metabolism—APOB—atherosclerosis	9.87e-06	7e-05	CbGpPWpGaD
Midazolam—SLC22A1—Metabolism—CAV1—atherosclerosis	9.84e-06	6.99e-05	CbGpPWpGaD
Midazolam—SLC22A1—Metabolism—APOA1—atherosclerosis	9.82e-06	6.97e-05	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—CYP27A1—atherosclerosis	9.76e-06	6.93e-05	CbGpPWpGaD
Midazolam—ABCB1—Transmembrane transport of small molecules—ALB—atherosclerosis	9.74e-06	6.91e-05	CbGpPWpGaD
Midazolam—CYP2E1—Metabolism—APOB—atherosclerosis	9.66e-06	6.86e-05	CbGpPWpGaD
Midazolam—CYP3A5—Metabolism—APOB—atherosclerosis	9.64e-06	6.84e-05	CbGpPWpGaD
Midazolam—CYP3A7—Metabolism—PIK3CG—atherosclerosis	9.64e-06	6.84e-05	CbGpPWpGaD
Midazolam—CYP2B6—Metabolism—GSTM1—atherosclerosis	9.6e-06	6.81e-05	CbGpPWpGaD
Midazolam—CYP2B6—Metabolism—LPL—atherosclerosis	9.42e-06	6.69e-05	CbGpPWpGaD
Midazolam—CYP2E1—Metabolism—GSTM1—atherosclerosis	9.4e-06	6.67e-05	CbGpPWpGaD
Midazolam—CYP3A5—Metabolism—GSTM1—atherosclerosis	9.38e-06	6.66e-05	CbGpPWpGaD
Midazolam—CYP3A7—Metabolism—PPARG—atherosclerosis	9.3e-06	6.6e-05	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—APOA2—atherosclerosis	9.26e-06	6.57e-05	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—PLA2G2A—atherosclerosis	9.26e-06	6.57e-05	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—ALOX5AP—atherosclerosis	9.26e-06	6.57e-05	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—ALOX15—atherosclerosis	9.26e-06	6.57e-05	CbGpPWpGaD
Midazolam—CYP2E1—Metabolism—LPL—atherosclerosis	9.23e-06	6.55e-05	CbGpPWpGaD
Midazolam—CYP3A5—Metabolism—LPL—atherosclerosis	9.21e-06	6.53e-05	CbGpPWpGaD
Midazolam—CYP2B6—Metabolism—GPX1—atherosclerosis	9.19e-06	6.52e-05	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—ABCG5—atherosclerosis	9.14e-06	6.49e-05	CbGpPWpGaD
Midazolam—CYP3A7—Metabolism—INS—atherosclerosis	9.12e-06	6.47e-05	CbGpPWpGaD
Midazolam—CYP2E1—Metabolism—GPX1—atherosclerosis	9e-06	6.39e-05	CbGpPWpGaD
Midazolam—CYP3A5—Metabolism—GPX1—atherosclerosis	8.98e-06	6.38e-05	CbGpPWpGaD
Midazolam—SLC22A1—Metabolism—PIK3CG—atherosclerosis	8.97e-06	6.36e-05	CbGpPWpGaD
Midazolam—CYP2B6—Metabolism—CD36—atherosclerosis	8.95e-06	6.35e-05	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—ABCA1—atherosclerosis	8.85e-06	6.28e-05	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—LPA—atherosclerosis	8.83e-06	6.27e-05	CbGpPWpGaD
Midazolam—CYP2E1—Metabolism—CD36—atherosclerosis	8.77e-06	6.22e-05	CbGpPWpGaD
Midazolam—CYP3A5—Metabolism—CD36—atherosclerosis	8.75e-06	6.21e-05	CbGpPWpGaD
Midazolam—SLC22A1—Metabolism—PPARG—atherosclerosis	8.65e-06	6.14e-05	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—BGN—atherosclerosis	8.55e-06	6.07e-05	CbGpPWpGaD
Midazolam—SLC22A1—Metabolism—INS—atherosclerosis	8.49e-06	6.02e-05	CbGpPWpGaD
Midazolam—CYP2B6—Metabolism—MTHFR—atherosclerosis	8.48e-06	6.02e-05	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—APOA5—atherosclerosis	8.47e-06	6.01e-05	CbGpPWpGaD
Midazolam—CYP3A7—Metabolism—ALB—atherosclerosis	8.36e-06	5.93e-05	CbGpPWpGaD
Midazolam—CYP2B6—Metabolism—PPARA—atherosclerosis	8.32e-06	5.91e-05	CbGpPWpGaD
Midazolam—CYP2E1—Metabolism—MTHFR—atherosclerosis	8.31e-06	5.9e-05	CbGpPWpGaD
Midazolam—CYP3A5—Metabolism—MTHFR—atherosclerosis	8.29e-06	5.88e-05	CbGpPWpGaD
Midazolam—CYP2E1—Metabolism—PPARA—atherosclerosis	8.15e-06	5.78e-05	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—PLA2G1B—atherosclerosis	8.15e-06	5.78e-05	CbGpPWpGaD
Midazolam—CYP3A5—Metabolism—PPARA—atherosclerosis	8.13e-06	5.77e-05	CbGpPWpGaD
Midazolam—CYP2B6—Metabolism—AGT—atherosclerosis	8.06e-06	5.72e-05	CbGpPWpGaD
Midazolam—CYP3A7—Metabolism—NOS3—atherosclerosis	8e-06	5.68e-05	CbGpPWpGaD
Midazolam—CYP2B6—Metabolism—APOE—atherosclerosis	7.9e-06	5.6e-05	CbGpPWpGaD
Midazolam—CYP2E1—Metabolism—AGT—atherosclerosis	7.89e-06	5.6e-05	CbGpPWpGaD
Midazolam—CYP3A5—Metabolism—AGT—atherosclerosis	7.88e-06	5.59e-05	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—ALOX5—atherosclerosis	7.87e-06	5.59e-05	CbGpPWpGaD
Midazolam—CYP2B6—Metabolism—CAV1—atherosclerosis	7.82e-06	5.55e-05	CbGpPWpGaD
Midazolam—CYP2B6—Metabolism—APOA1—atherosclerosis	7.81e-06	5.54e-05	CbGpPWpGaD
Midazolam—SLC22A1—Metabolism—ALB—atherosclerosis	7.78e-06	5.52e-05	CbGpPWpGaD
Midazolam—CYP2E1—Metabolism—APOE—atherosclerosis	7.73e-06	5.49e-05	CbGpPWpGaD
Midazolam—CYP3A5—Metabolism—APOE—atherosclerosis	7.72e-06	5.48e-05	CbGpPWpGaD
Midazolam—CYP2E1—Metabolism—CAV1—atherosclerosis	7.66e-06	5.44e-05	CbGpPWpGaD
Midazolam—CYP3A5—Metabolism—CAV1—atherosclerosis	7.65e-06	5.43e-05	CbGpPWpGaD
Midazolam—CYP2E1—Metabolism—APOA1—atherosclerosis	7.65e-06	5.43e-05	CbGpPWpGaD
Midazolam—CYP3A5—Metabolism—APOA1—atherosclerosis	7.63e-06	5.41e-05	CbGpPWpGaD
Midazolam—UGT1A4—Metabolism—AKT1—atherosclerosis	7.61e-06	5.4e-05	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—HMOX1—atherosclerosis	7.6e-06	5.39e-05	CbGpPWpGaD
Midazolam—SLC22A1—Metabolism—NOS3—atherosclerosis	7.44e-06	5.28e-05	CbGpPWpGaD
Midazolam—CYP3A7—Metabolism—PTGS2—atherosclerosis	7.32e-06	5.19e-05	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—APOB—atherosclerosis	7.28e-06	5.16e-05	CbGpPWpGaD
Midazolam—CYP2B6—Metabolism—PIK3CG—atherosclerosis	7.13e-06	5.06e-05	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—GSTM1—atherosclerosis	7.08e-06	5.02e-05	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—NAMPT—atherosclerosis	7.06e-06	5.01e-05	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—LIPC—atherosclerosis	7.01e-06	4.98e-05	CbGpPWpGaD
Midazolam—CYP2E1—Metabolism—PIK3CG—atherosclerosis	6.98e-06	4.95e-05	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—APOC3—atherosclerosis	6.97e-06	4.95e-05	CbGpPWpGaD
Midazolam—CYP3A5—Metabolism—PIK3CG—atherosclerosis	6.97e-06	4.94e-05	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—LPL—atherosclerosis	6.95e-06	4.93e-05	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—LDLR—atherosclerosis	6.93e-06	4.92e-05	CbGpPWpGaD
Midazolam—CYP2B6—Metabolism—PPARG—atherosclerosis	6.88e-06	4.88e-05	CbGpPWpGaD
Midazolam—SLC22A1—Metabolism—PTGS2—atherosclerosis	6.81e-06	4.83e-05	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—GPX1—atherosclerosis	6.78e-06	4.81e-05	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—CETP—atherosclerosis	6.77e-06	4.8e-05	CbGpPWpGaD
Midazolam—CYP2B6—Metabolism—INS—atherosclerosis	6.75e-06	4.79e-05	CbGpPWpGaD
Midazolam—CYP2E1—Metabolism—PPARG—atherosclerosis	6.74e-06	4.78e-05	CbGpPWpGaD
Midazolam—CYP3A5—Metabolism—PPARG—atherosclerosis	6.72e-06	4.77e-05	CbGpPWpGaD
Midazolam—CYP2E1—Metabolism—INS—atherosclerosis	6.61e-06	4.69e-05	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—CD36—atherosclerosis	6.6e-06	4.69e-05	CbGpPWpGaD
Midazolam—CYP3A5—Metabolism—INS—atherosclerosis	6.59e-06	4.68e-05	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—SCARB1—atherosclerosis	6.48e-06	4.6e-05	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—MTHFR—atherosclerosis	6.26e-06	4.44e-05	CbGpPWpGaD
Midazolam—CYP2B6—Metabolism—ALB—atherosclerosis	6.18e-06	4.39e-05	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—PPARA—atherosclerosis	6.14e-06	4.36e-05	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—HMGCR—atherosclerosis	6.12e-06	4.34e-05	CbGpPWpGaD
Midazolam—CYP2E1—Metabolism—ALB—atherosclerosis	6.06e-06	4.3e-05	CbGpPWpGaD
Midazolam—CYP3A5—Metabolism—ALB—atherosclerosis	6.04e-06	4.29e-05	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—AGT—atherosclerosis	5.94e-06	4.22e-05	CbGpPWpGaD
Midazolam—CYP2B6—Metabolism—NOS3—atherosclerosis	5.92e-06	4.2e-05	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—APOE—atherosclerosis	5.82e-06	4.13e-05	CbGpPWpGaD
Midazolam—CYP2E1—Metabolism—NOS3—atherosclerosis	5.79e-06	4.11e-05	CbGpPWpGaD
Midazolam—CYP3A5—Metabolism—NOS3—atherosclerosis	5.78e-06	4.1e-05	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—CAV1—atherosclerosis	5.77e-06	4.1e-05	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—APOA1—atherosclerosis	5.76e-06	4.09e-05	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—ABCA1—atherosclerosis	5.46e-06	3.87e-05	CbGpPWpGaD
Midazolam—CYP2B6—Metabolism—PTGS2—atherosclerosis	5.41e-06	3.84e-05	CbGpPWpGaD
Midazolam—CYP2E1—Metabolism—PTGS2—atherosclerosis	5.3e-06	3.76e-05	CbGpPWpGaD
Midazolam—CYP3A5—Metabolism—PTGS2—atherosclerosis	5.29e-06	3.75e-05	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—PIK3CG—atherosclerosis	5.26e-06	3.73e-05	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—PPARG—atherosclerosis	5.07e-06	3.6e-05	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—INS—atherosclerosis	4.98e-06	3.53e-05	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—HMOX1—atherosclerosis	4.68e-06	3.32e-05	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—ALB—atherosclerosis	4.56e-06	3.24e-05	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—APOB—atherosclerosis	4.48e-06	3.18e-05	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—NOS3—atherosclerosis	4.36e-06	3.1e-05	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—GSTM1—atherosclerosis	4.36e-06	3.1e-05	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—LPL—atherosclerosis	4.28e-06	3.04e-05	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—GPX1—atherosclerosis	4.18e-06	2.96e-05	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—CD36—atherosclerosis	4.07e-06	2.89e-05	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—PTGS2—atherosclerosis	3.99e-06	2.83e-05	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—MTHFR—atherosclerosis	3.85e-06	2.74e-05	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—PPARA—atherosclerosis	3.78e-06	2.68e-05	CbGpPWpGaD
Midazolam—CYP3A7—Metabolism—AKT1—atherosclerosis	3.68e-06	2.61e-05	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—AGT—atherosclerosis	3.66e-06	2.6e-05	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—APOE—atherosclerosis	3.59e-06	2.55e-05	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—CAV1—atherosclerosis	3.56e-06	2.52e-05	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—APOA1—atherosclerosis	3.55e-06	2.52e-05	CbGpPWpGaD
Midazolam—SLC22A1—Metabolism—AKT1—atherosclerosis	3.42e-06	2.43e-05	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—PIK3CG—atherosclerosis	3.24e-06	2.3e-05	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—PPARG—atherosclerosis	3.13e-06	2.22e-05	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—INS—atherosclerosis	3.07e-06	2.18e-05	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—ALB—atherosclerosis	2.81e-06	1.99e-05	CbGpPWpGaD
Midazolam—CYP2B6—Metabolism—AKT1—atherosclerosis	2.72e-06	1.93e-05	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—NOS3—atherosclerosis	2.69e-06	1.91e-05	CbGpPWpGaD
Midazolam—CYP2E1—Metabolism—AKT1—atherosclerosis	2.66e-06	1.89e-05	CbGpPWpGaD
Midazolam—CYP3A5—Metabolism—AKT1—atherosclerosis	2.66e-06	1.89e-05	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—PTGS2—atherosclerosis	2.46e-06	1.74e-05	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—AKT1—atherosclerosis	2.01e-06	1.42e-05	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—AKT1—atherosclerosis	1.24e-06	8.77e-06	CbGpPWpGaD
